Search Results - "Shechter, M"

Refine Results
  1. 1

    Screening Strategies for Patients on the Kidney Transplant Waiting List by Sabouri, Alireza, Huh, Woonghee Tim, Shechter, Steven M.

    Published in Operations research (01-09-2017)
    “…Transplant centers screen patients on the kidney transplant waiting list to identify patients with severe conditions such as cardiovascular disease (CVD),…”
    Get full text
    Journal Article
  2. 2

    A combined sustainability index for electricity efficiency measures by Goldrath, T., Ayalon, O., Shechter, M.

    Published in Energy policy (01-11-2015)
    “…One of the most substantial tools that serve decision makers in their efforts to reduce greenhouse gas emissions includes energy efficiency measures that in…”
    Get full text
    Journal Article
  3. 3

    Periodontitis and Cardiovascular Diseases. Consensus Report by Sanz, M, Del Castillo, A Marco, Jepsen, S, Gonzalez-Juanatey, J R, D'Aiuto, F, Bouchard, P, Chapple, I, Dietrich, T, Gotsman, I, Graziani, F, Herrera, D, Loos, B, Madianos, P, Michel, J B, Perel, P, Pieske, B, Shapira, L, Shechter, M, Tonetti, M, Vlachopoulos, C, Wimmer, G

    Published in Global heart (03-02-2020)
    “…In Europe cardiovascular disease (CVD) is responsible for 3.9 million deaths (45% of deaths), being ischaemic heart disease, stroke, hypertension (leading to…”
    Get full text
    Journal Article
  4. 4

    Timing of Arteriovenous Fistula Creation in Patients With CKD: A Decision Analysis by Shechter, Steven M., PhD, Skandari, M. Reza, MS, Zalunardo, Nadia, MD SM

    Published in American journal of kidney diseases (01-01-2014)
    “…Background The optimal time for arteriovenous fistula (AVF) referral is uncertain. Improving the timeliness of referral may reduce central venous catheter…”
    Get full text
    Journal Article
  5. 5

    Preferences for rank in competition: Is first-place seeking stronger than last-place aversion? by Shechter, Steven M., Hardisty, David J.

    Published in Judgment and decision making (01-03-2020)
    “…Abstract The use of gamification to motivate engagement has greatly increased the number of ways in which people compete. Many of these competitions allow…”
    Get full text
    Journal Article
  6. 6

    Cost-effectiveness Analysis of Vascular Access Referral Policies in CKD by Shechter, Steven M., PhD, Chandler, Talon, BASc, Skandari, M. Reza, PhD, Zalunardo, Nadia, MD, SM

    Published in American journal of kidney diseases (01-09-2017)
    “…Background The optimal timing of vascular access referral for patients with chronic kidney disease who may need hemodialysis (HD) is a pressing question in…”
    Get full text
    Journal Article
  7. 7

    Aspirin withdrawal in patients treated with ticagrelor presenting with non‐ST elevation myocardial infarction by Beigel, R., Mazin, I., Koifman, E., Shechter, M., Pres, H., Shlomo, N., Rosenberg, N., Asher, E., Matetzky, S.

    Published in Journal of thrombosis and haemostasis (01-04-2018)
    “…Essentials Strong P2Y12 blockade may cause platelet inhibition that is only minimally enhanced by aspirin. We evaluated aspirin withdrawal on platelet…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Technical Note—Trading Off Quick versus Slow Actions in Optimal Search by Shechter, Steven M., Ghassemi, Farhad, Gocgun, Yasin, Puterman, Martin L.

    Published in Operations research (01-03-2015)
    “…We consider the search for a target whose precise location is uncertain. The search region is divided into grid cells, and the searcher decides which cell to…”
    Get full text
    Journal Article
  10. 10

    Efficient solutions for a class of optimal stopping problems by Shechter, Steven M.

    Published in Operations research letters (01-09-2012)
    “…We show that a practical class of optimal stopping problems can be solved in at most N iterations of policy iteration. Under a lower triangularity assumption,…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Oral magnesium therapy improves endothelial function in patients with coronary artery disease by SHECHTER, Michael, SHARIR, Michael, LABRADOR, Maura J, FORRESTER, James, SILVER, Burton, MERZ, C. Noel

    Published in Circulation (New York, N.Y.) (07-11-2000)
    “…Magnesium blocks many of the physiological actions of calcium. Nevertheless, the impact of magnesium supplementation on endothelial function and exercise…”
    Get full text
    Journal Article
  13. 13

    Oral magnesium therapy, exercise heart rate, exercise tolerance, and myocardial function in coronary artery disease patients by Pokan, R, Hofmann, P, von Duvillard, S P, Smekal, G, Wonisch, M, Lettner, K, Schmid, P, Shechter, M, Silver, B, Bachl, N

    Published in British journal of sports medicine (01-09-2006)
    “…Background: Previous studies have demonstrated that in patients with coronary artery disease (CAD) upward deflection of the heart rate (HR) performance curve…”
    Get full text
    Journal Article
  14. 14

    A Clinically Based Discrete-Event Simulation of End-Stage Liver Disease and the Organ Allocation Process by Shechter, Steven M., Bryce, Cindy L., Alagoz, Oguzhan, Kreke, Jennifer E., Stahl, James E., Schaefer, Andrew J., Angus, Derek C., Roberts, Mark S.

    Published in Medical decision making (01-03-2005)
    “…Background . The optimal allocation of scarce donor livers is a contentious health care issue requiring careful analysis. The objective of this article was to…”
    Get full text
    Journal Article
  15. 15

    Obese adults with primary growth hormone resistance (Laron Syndrome) have normal endothelial function by Shechter, M, Ginsberg, S, Scheinowitz, M, Feinberg, M.S, Laron, Z

    Published in Growth hormone & IGF research (01-04-2007)
    “…Abstract Objective Classic Laron Syndrome (LS) is a recessive disease of insulin-like growth factor I (IGF-I) deficiency and primary growth hormone…”
    Get full text
    Journal Article
  16. 16

    The role of magnesium as antithrombotic therapy by Shechter, M

    Published in Wiener medizinische Wochenschrift (2000)
    “…Meta-analysis of previous relatively small clinical trials, comparing intravenous magnesium with placebo in acute myocardial infarction (AMI) patients, mainly…”
    Get more information
    Journal Article
  17. 17
  18. 18
  19. 19

    The Optimal Time to Initiate HIV Therapy Under Ordered Health States by Shechter, Steven M, Bailey, Matthew D, Schaefer, Andrew J, Roberts, Mark S

    Published in Operations research (01-01-2008)
    “…The question of when to initiate HIV treatment is considered the most important question in HIV care today. Benefits of delaying therapy include avoiding the…”
    Get full text
    Journal Article
  20. 20

    Admission serum magnesium levels associated with short- and long-term clinical outcomes in COVID-19 patients by Segev, A, Sagir, A, Matezky, S, Atar, S, Shechter, M

    Published in European heart journal (03-10-2022)
    “…Abstract Introduction In the face of the global pandemic coronavirus disease 2019 (COVID-19) has created, readily available prognostic markers may be of great…”
    Get full text
    Journal Article